Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases

Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases [Turk J Hematol]

Turk J Hematol. 2018; 35(4): 312-313 | DOI: 10.4274/tjh.2017.0464

Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases

Rafet Eren, Elif Suyan�
University of Health Sciences, �stanbul Training and Research Hospital, Clinic of Hematology, �stanbul, Turkey

Keywords: Kronik lenfositik l�semi, Otoimm�n hemolitik anemi, Bendamustin, Rit�ksimab

Bendamustin ve Rituksimab Tedavisi ile Erken Direkt Antiglob�lin Testi Negatifli�i Elde Edilen �ki Kronik Lenfositik L�semi Olgusu

Rafet Eren, Elif Suyan�
University of Health Sciences, �stanbul Training and Research Hospital, Clinic of Hematology, �stanbul, Turkey

Anahtar Kelimeler: Chronic lymphocytic leukemia, Autoimmune hemolytic anemia, Bendamustine, Rituximab

Rafet Eren, Elif Suyan�. Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases. Turk J Hematol. 2018; 35(4): 312-313

Corresponding Author: Elif Suyan�, T�rkiye

TOOLS

Full Text PDF

Download citation

RIS

EndNote

BibTex

Medlars

Procite

Reference Manager

Share with email

Send email to author

Similar articles

PubMed

Google Scholar

In authors and institutes

In titles and abstracts

In keywords

In all


	E-ISSN: 1308-5263
Archive Most Accessed Articles Most Cited Articles Aims and Scope Instructions For Authors Editorial Board Advisory Board Manuscript Submission Why to Submit Search Contact